getting a stent and those having surgery. The study was co-funded by the National Institutes of Health and Abbott Laboratories. In January and FDA panel of outside experts voted 7-3 that Acculink's benefits outweighed its risks for the new use. However,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA expands use of stroke treatment device
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account